XML 95 R77.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes - Additional Information (Detail) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Line Items]    
Valuation allowance period increase $ 51,800,000  
Unrecognized tax benefits $ 0  
Tax credit carryforwards expiration year 2038  
Accrued penalties and provisions for interest $ 0  
Current and deferred income tax expense $ 100,000 $ 300,000
Company's effective tax rate 0.00%  
U.S. statutory tax rate 21.00%  
Total gross deferred tax assets before valuation allowance $ 108,634,000 $ 57,121,000
Cumulative Changes Ownership Interest 50.00%  
Domestic Tax Jurisdiction [Member]    
Income Tax Disclosure [Line Items]    
Net operating loss carryforwards $ 121,300,000  
State and Local Jurisdiction [Member]    
Income Tax Disclosure [Line Items]    
Net operating loss carryforwards $ 112,100,000  
Net operating loss carryforwards, expiration year 2040  
Research Tax Credit Carryforward [Member] | Domestic Tax Jurisdiction [Member]    
Income Tax Disclosure [Line Items]    
Research and development tax credit carryforwards $ 6,200,000  
Research Tax Credit Carryforward [Member] | State and Local Jurisdiction [Member]    
Income Tax Disclosure [Line Items]    
Research and development tax credit carryforwards $ 2,300,000